No results for ‘’
Windlas Biotech Ltd
₹829.45
(0.71%)
Wed, 17 Jun 2026, 04:00 am
Health Technology
Pharmaceuticals: Major
24.5KWindlas Biotech Enterprise Value (EV)
| Particulars | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 11.31 | 11.43 | 18.38 | 36.07 |
| Price to book ratio | 0 | 0 | 0 | 0 | 1.16 | 1.17 | 2.37 | 4.31 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0.93 | 0.95 | 1.70 | 2.90 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 41.90 | 7.53 | 9.76 | 33.62 |
| Enterprise value | 0 | 0 | 0 | 0 | 259Cr | 360Cr | 869Cr | 1993Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 4.98 | 5.95 | 11.04 | 21.05 |
| Debt to equity ratio | 0.46 | 0.16 | 0.14 | 0.16 | 0.02 | 0.01 | 0.01 | 0.06 |
| Return on equity % | 0 | 40.06 | 8.04 | 7.75 | 12.83 | 10.70 | 13.66 | 12.76 |
Windlas Biotech Ltd Enterprise Value
The Windlas Biotech Ltd Enterprise Value is a key financial metric used by investors to evaluate Windlas Biotech Ltd's valuation, profitability, and overall financial performance. Tracking the Windlas Biotech Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Windlas Biotech Ltd (NSE: WINDLAS, BSE: 543329) is currently trading at ₹829.45, with a market capitalization of ₹1719.2Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Windlas Biotech Ltd Enterprise Value is essential for fundamental analysis.
Windlas Biotech Ltd Enterprise Value Current Value
The current Windlas Biotech Ltd Enterprise Value stands at 1993Cr.
The latest Windlas Biotech Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Windlas Biotech Ltd Enterprise Value Historical Trend
The Windlas Biotech Ltd Enterprise Value has shown the following historical trend:
- 2024: 1993Cr
- 2023: 869Cr
- 2022: 360Cr
- 2021: 259Cr
- 2020: 0
The recent rise in Windlas Biotech Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Windlas Biotech Ltd Enterprise Value Indicates for Investors
The Windlas Biotech Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Windlas Biotech Ltd.
Windlas Biotech Ltd Enterprise Value Analysis Summary
The Windlas Biotech Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Windlas Biotech Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Windlas Biotech Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.